Investing

Top Day Trader Alerts (BPAX, BP, FTBK, GS, POZN, SIRI)

These are this morning’s top day trader and active trader alerts.  We have a link to more detail and analysis on each where applicable at VSInvestor.com:

Biosante Pharmaceuticals, Inc. (NASDAQ: BPAX) is up about 7% on prostate cancer trial news.

BP plc (NYSE: BP) is down 3% at 50.55 this morning as the Gulf oil spill continues to get worse and worse.

Frontier Financial Corporation (NASDAQ: FTBK) looks like the daily implosion.

Goldman Sachs Group Inc. (NYSE: GS) is trading higher after being defended by Warren Buffett this weekend.

POZEN, Inc. (NASDAQ: POZN) is challenging 52-week highs as the FDA approved the its arthritis treatment Vimovo.

SIRIUS XM Radio Inc. (NASDAQ: SIRI) will be key to watch ahead of earnings as shares are challenging 52-week highs.

You can join our free daily email distribution list to hear more about dividend trends, analyst upgrades and downgrades, top day trader and active trader alerts, news on Buffett and other investment gurus, IPOs, secondary offerings, private equity, and more.

JON C. OGG

Sponsor: 5 best investments for 2010 – The next nine months represent a bold new era for investors.

Credit Card Companies Are Doing Something Nuts

Credit card companies are at war. The biggest issuers are handing out free rewards and benefits to win the best customers.

It’s possible to find cards paying unlimited 1.5%, 2%, and even more today. That’s free money for qualified borrowers, and the type of thing that would be crazy to pass up. Those rewards can add up to thousands of dollars every year in free money, and include other benefits as well.

We’ve assembled some of the best credit cards for users today.  Don’t miss these offers because they won’t be this good forever.

 

Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.